Prue H. Hart
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Prue H. Hart has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
John J. Finlay-Jones
8 shared publicationsJ.J. Finlay-Jones
Department of Microbiology and Infectious Diseases, School of Medicine, Flinders University, GPO Box 2100, Adelaide, Australia 5001
5 shared publicationsMichele A. Grimbaldeston
5 shared publicationsC. Brand
Department of Microbiology and Infectious Diseases, School of Medicine and Flinders Medical Research Institute, Flinders University, Adelaide, Australia
4 shared publicationsGeorgina J. Swift
4 shared publicationsAleksandra Jaksic
2 shared publications
Latest Publications
- 1 February 2003
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 148 (2) , 300-306
The effect of ultraviolet radiation exposure on the prevalence of mast cells in human skin
Summary Background Dermal mast cells have been implicated as important effector cells in innate immunity, hypersensitivity responses and ultraviolet (UV)B-induced suppression of cell-mediated immune...
- 1 February 2003
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 148 (2) , 300-306
The effect of ultraviolet radiation exposure on the prevalence of mast cells in human skin
Summary Background Dermal mast cells have been implicated as important effector cells in innate immunity, hypersensitivity responses and ultraviolet (UV)B-induced suppression of cell-mediated immune...
- 1 December 2002
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 147 (6) , 1212-1217
Tea tree oil reduces histamine-induced skin inflammation
Summary Background Tea tree oil is the essential oil steam-distilled from Melaleuca alternifolia , an Australian native plant. In recent years it has become increasingly popu...
- 1 December 2002
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 147 (6) , 1212-1217
Tea tree oil reduces histamine-induced skin inflammation
Summary Background Tea tree oil is the essential oil steam-distilled from Melaleuca alternifolia , an Australian native plant. In recent years it has become increasingly popu...
- 1 June 2002
- Published by Springer Nature in Inflammation Research
- Vol. 51 (6) , 283-289
Tea tree oil reduces histamine-induced oedema in murine ears
Objective: To examine the effect of topically applied tea tree oil (TTO) on histamine-induced oedema in the ears of mice.¶Methods and results: For BALB/c mice, 10 μ undiluted TTO applied immediately after, but not 30 min before intradermal injection of 600 μg histamine in 10 μl, significantly suppressed oedema development. TTO applied after histamine injection also suppressed histamine-induced oedema in C57/BL6 mice. TTO applied immediately after intradermal injection of compound 48/80 (200 μg in 10 μl saline) also significantly reduced ear swelling. TTO suppressed histamine-induced oedema to the same extent in capsaicin-treated (neuropeptide-depleted) and control mice which suggests that TTO does not inhibit histamine-induced oedema by regulating the activity of peripheral sensory neurons. Terpinen-4-ol, the major water-soluble component of TTO, was equivalent in potency to TTO in the suppression of histamine-induced ear swelling.¶Conclusion: Topical application of TTO, and in particular terpinen-4-ol, may be effective in controlling histamine-induced oedema often associated with Type I allergic immediate hypersensitivities.
- 1 June 2002
- Published by Springer Nature in Inflammation Research
- Vol. 51 (6) , 283-289
Tea tree oil reduces histamine-induced oedema in murine ears
Objective: To examine the effect of topically applied tea tree oil (TTO) on histamine-induced oedema in the ears of mice.¶Methods and results: For BALB/c mice, 10 μ undiluted TTO applied immediately after, but not 30 min before intradermal injection of 600 μg histamine in 10 μl, significantly suppressed oedema development. TTO applied after histamine injection also suppressed histamine-induced oedema in C57/BL6 mice. TTO applied immediately after intradermal injection of compound 48/80 (200 μg in 10 μl saline) also significantly reduced ear swelling. TTO suppressed histamine-induced oedema to the same extent in capsaicin-treated (neuropeptide-depleted) and control mice which suggests that TTO does not inhibit histamine-induced oedema by regulating the activity of peripheral sensory neurons. Terpinen-4-ol, the major water-soluble component of TTO, was equivalent in potency to TTO in the suppression of histamine-induced ear swelling.¶Conclusion: Topical application of TTO, and in particular terpinen-4-ol, may be effective in controlling histamine-induced oedema often associated with Type I allergic immediate hypersensitivities.
- 1 May 2002
- Published by Springer Nature in Inflammation Research
- Vol. 51 (5) , 236-244
Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response
Objective: To examine the anti-inflammatory activities of tea tree oil (TTO) in vivo.¶Methods: Mice were sensitized to a chemical hapten, trinitrochlorobenzene, on their ventral skin and 7 days later challenged (or re-exposed) on their dorsal skin with the same hapten.¶Results: TTO applied 30 min before or up to 7 h after to the same dorsal site as hapten challenge caused a significant reduction in skin swelling after 24 h. TTO reduced oedema but not the influx of inflammatory cells. This finding was supported by the inability of TTO to suppress TNFa-induced E-selectin expression by human umbilical vein endothelial cells. TTO did not suppress irritant- or ultraviolet B-induced oedema.¶Conclusion: Topical TTO, specifically the TTO components, terpinen-4-ol and α-terpineol can regulate the oedema associated with the efferent phase of a contact hypersensitivity response.
- 1 May 2002
- Published by Springer Nature in Inflammation Research
- Vol. 51 (5) , 236-244
Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response
Objective: To examine the anti-inflammatory activities of tea tree oil (TTO) in vivo.¶Methods: Mice were sensitized to a chemical hapten, trinitrochlorobenzene, on their ventral skin and 7 days later challenged (or re-exposed) on their dorsal skin with the same hapten.¶Results: TTO applied 30 min before or up to 7 h after to the same dorsal site as hapten challenge caused a significant reduction in skin swelling after 24 h. TTO reduced oedema but not the influx of inflammatory cells. This finding was supported by the inability of TTO to suppress TNFa-induced E-selectin expression by human umbilical vein endothelial cells. TTO did not suppress irritant- or ultraviolet B-induced oedema.¶Conclusion: Topical TTO, specifically the TTO components, terpinen-4-ol and α-terpineol can regulate the oedema associated with the efferent phase of a contact hypersensitivity response.
- 1 October 2001
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 117 (4) , 886-891
cis-Urocanic Acid Stimulates Neuropeptide Release from Peripheral Sensory Nerves
- 1 October 2001
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 117 (4) , 886-891
cis-Urocanic Acid Stimulates Neuropeptide Release from Peripheral Sensory Nerves
- 1 April 2001
- Published by Springer Nature in Inflammation Research
- Vol. 50 (4) , 213-219
The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro
Objective: To evaluate the regulatory properties of the essential oil of Melaleuca alternifolia (tea tree oil) on the production of oxygen derived reactive species by human peripheral blood leukocytes activated in vitro.¶Materials and methods: The ability of tea tree oil to reduce superoxide production by neutrophils and monocytes stimulated with N-formyl-methionyl-leucyl-phenylalanine (fMLP), lipopolysaccharide (LPS) or phorbol 12-myristate 13-acetate (PMA) was examined.¶Results: The water-soluble fraction of tea tree oil had no significant effect on agonist-stimulated superoxide production by neutrophils, but significantly and dose-dependently suppressed agonist-stimulated superoxide production by monocytes. This suppression was not due to cell death. Chemical analysis identified the water-soluble components to be terpinen-4-ol, α-terpineol and 1,8-cineole. When examined individually, terpinen-4-ol significantly suppressed fMLP- and LPS- but not PMA-stimulated superoxide production; α-terpineol significantly suppressed fMLP-, LPS- and PMA-stimulated superoxide production; 1,8-cineole was without effect.¶Conclusion: Tea tree oil components suppress the production of superoxide by monocytes, but not neutrophils, suggesting the potential for selective regulation of cell types by these components during inflammation.¶
- 1 April 2001
- Published by Springer Nature in Inflammation Research
- Vol. 50 (4) , 213-219
The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro
Objective: To evaluate the regulatory properties of the essential oil of Melaleuca alternifolia (tea tree oil) on the production of oxygen derived reactive species by human peripheral blood leukocytes activated in vitro.¶Materials and methods: The ability of tea tree oil to reduce superoxide production by neutrophils and monocytes stimulated with N-formyl-methionyl-leucyl-phenylalanine (fMLP), lipopolysaccharide (LPS) or phorbol 12-myristate 13-acetate (PMA) was examined.¶Results: The water-soluble fraction of tea tree oil had no significant effect on agonist-stimulated superoxide production by neutrophils, but significantly and dose-dependently suppressed agonist-stimulated superoxide production by monocytes. This suppression was not due to cell death. Chemical analysis identified the water-soluble components to be terpinen-4-ol, α-terpineol and 1,8-cineole. When examined individually, terpinen-4-ol significantly suppressed fMLP- and LPS- but not PMA-stimulated superoxide production; α-terpineol significantly suppressed fMLP-, LPS- and PMA-stimulated superoxide production; 1,8-cineole was without effect.¶Conclusion: Tea tree oil components suppress the production of superoxide by monocytes, but not neutrophils, suggesting the potential for selective regulation of cell types by these components during inflammation.¶
- 1 April 2001
- Published by Wiley in Immunology & Cell Biology
- Vol. 79 (2) , 149-153
Regulation of the inflammatory response in asthma by mast cell products
In airways, mast cells lie adjacent to nerves, blood vessels and lymphatics, which highlights their pivotal importance in regulating allergic inflammatory processes. In asthma, mast cells are predominantly activated by IgE receptor cross linking. In response to activation, preformed mediators that are stored bound to proteoglycans, for example, TNF‐α, IL‐4, IL‐13, histamine, tryptase and chymase, are released. New synthesis of arachidonic acid metabolites (leukotriene C4 (LTC4), leukotriene B4 (LTB4) and prostaglandin D2 (PGD2)) and further cytokines is stimulated. Mediators from degranulating mast cells are critical to the pathology of the asthmatic lung. Mast cell proteases stimulate tissue remodelling, neuropeptide inactivation and enhanced mucus secretion. Histamine stimulates smooth muscle cell contraction, vasodilatation and increased venular permeability and further mucus secretion. Histamine induces IL‐16 production by CD8+ cells and airway epithelial cells; IL‐16 is an important early chemotactic factor for CD4+ lymphocytes. LTC4, LTB4 and PGD2 affect venular permeability and can regulate the activation of immune cells. The best characterized mast cell cytokine in asthmatic inflammation is TNF‐α, which induces adhesion molecules on endothelial cells and subsequent transmigration of inflammatory leucocytes. IL‐13 is critical to development of allergic asthma, although its mode of action is less clear.
- 1 April 2001
- Published by Wiley in Immunology & Cell Biology
- Vol. 79 (2) , 149-153
Regulation of the inflammatory response in asthma by mast cell products
In airways, mast cells lie adjacent to nerves, blood vessels and lymphatics, which highlights their pivotal importance in regulating allergic inflammatory processes. In asthma, mast cells are predominantly activated by IgE receptor cross linking. In response to activation, preformed mediators that are stored bound to proteoglycans, for example, TNF‐α, IL‐4, IL‐13, histamine, tryptase and chymase, are released. New synthesis of arachidonic acid metabolites (leukotriene C4 (LTC4), leukotriene B4 (LTB4) and prostaglandin D2 (PGD2)) and further cytokines is stimulated. Mediators from degranulating mast cells are critical to the pathology of the asthmatic lung. Mast cell proteases stimulate tissue remodelling, neuropeptide inactivation and enhanced mucus secretion. Histamine stimulates smooth muscle cell contraction, vasodilatation and increased venular permeability and further mucus secretion. Histamine induces IL‐16 production by CD8+ cells and airway epithelial cells; IL‐16 is an important early chemotactic factor for CD4+ lymphocytes. LTC4, LTB4 and PGD2 affect venular permeability and can regulate the activation of immune cells. The best characterized mast cell cytokine in asthmatic inflammation is TNF‐α, which induces adhesion molecules on endothelial cells and subsequent transmigration of inflammatory leucocytes. IL‐13 is critical to development of allergic asthma, although its mode of action is less clear.
- Open Access
- 1 January 2001
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 28 (1-2) , 1-8
Sunlight, Immunosuppression And Skin Cancer: Role Of Histamine And Mast Cells
SUMMARY: 1. The development into tumours of skin cells transformed by ultraviolet (UV) B radiation of wavelengths 290–320 nm is enhanced by the ability of UVB to suppress an immune response that would otherwise destroy them. Ultraviolet B‐induced immunomodulation may be by multiple mechanisms, but generally manifests in an antigen‐presenting cell defect and an altered cytokine environment in the draining lymph nodes.2. Immune responses to microbial or self‐antigens may be dysfunctional by similar mechanisms following UVB exposure.3. Earliest‐acting intermediates in the initiation of UVB‐induced immunosuppression are the UVB absorbers (photoreceptors) of the skin, notably DNA resulting in immunoregulatory cytokine production, and trans‐urocanic acid (UCA), which, upon isomerization to its cis isomer, signals downstream immunosuppressive events.4. In mice, dermal mast cells are critical to UVB‐induced systemic immunomodulation. In mice, there is a functional link as well as a linear relationship between the prevalence of histamine‐staining dermal mast cells and the log of the dose of UVB required for 50% immunosuppression. Studies with histamine receptor antagonists support histamine as the main product of mast cells involved. Histamine acts in large part via a prostanoid‐dependent pathway.5. Approximately 50% of humans and greater than 90% of patients with non‐melanoma skin cancer are UVB susceptible for suppression of a contact hypersensitivity response. Neither cytokine polymorphisms nor UVB‐induced levels of cis‐UCA in irradiated skin have been linked to UVB susceptibility. Patients with basal cell carcinomas (BCC) have an increased dermal mast cell prevalence in non‐sun‐exposed buttock skin. We propose that mast cells function in humans, as in mice, by initiating immunosuppression and, thereby, allowing a permissive environment for BCC development.
- 1 January 2001
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 28 (1-2) , 1-8
Open AccessSunlight, Immunosuppression And Skin Cancer: Role Of Histamine And Mast Cells
SUMMARY: 1. The development into tumours of skin cells transformed by ultraviolet (UV) B radiation of wavelengths 290–320 nm is enhanced by the ability of UVB to suppress an immune response that would otherwise destroy them. Ultraviolet B‐induced immunomodulation may be by multiple mechanisms, but generally manifests in an antigen‐presenting cell defect and an altered cytokine environment in the draining lymph nodes.2. Immune responses to microbial or self‐antigens may be dysfunctional by similar mechanisms following UVB exposure.3. Earliest‐acting intermediates in the initiation of UVB‐induced immunosuppression are the UVB absorbers (photoreceptors) of the skin, notably DNA resulting in immunoregulatory cytokine production, and trans‐urocanic acid (UCA), which, upon isomerization to its cis isomer, signals downstream immunosuppressive events.4. In mice, dermal mast cells are critical to UVB‐induced systemic immunomodulation. In mice, there is a functional link as well as a linear relationship between the prevalence of histamine‐staining dermal mast cells and the log of the dose of UVB required for 50% immunosuppression. Studies with histamine receptor antagonists support histamine as the main product of mast cells involved. Histamine acts in large part via a prostanoid‐dependent pathway.5. Approximately 50% of humans and greater than 90% of patients with non‐melanoma skin cancer are UVB susceptible for suppression of a contact hypersensitivity response. Neither cytokine polymorphisms nor UVB‐induced levels of cis‐UCA in irradiated skin have been linked to UVB susceptibility. Patients with basal cell carcinomas (BCC) have an increased dermal mast cell prevalence in non‐sun‐exposed buttock skin. We propose that mast cells function in humans, as in mice, by initiating immunosuppression and, thereby, allowing a permissive environment for BCC development.
- 1 November 2000
- Published by Springer Nature in Inflammation Research
- Vol. 49 (11) , 619-626
Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes
Objective and Design: To evaluate potential anti-inflammatory properties of tea tree oil, the essential oil steam distilled from the Australian native plant, Melaleuca alternifolia.¶Material and Methods: The ability of tea tree oil to reduce the production in vitro of tumour necrosis factor-α (TNFα), interleukin (IL)-1β, IL-8, IL-10 and prostaglandin E2 (PGE2) by lipopolysaccharide (LPS)-activated human peripheral blood monocytes was examined.¶Results: Tea tree oil emulsified by sonication in a glass tube into culture medium containing 10% fetal calf serum (FCS) was toxic for monocytes at a concentration of 0.016% v/v. However, the water soluble components of tea tree oil at concentrations equivalent to 0.125% significantly suppressed LPS-induced production of TNFα, IL-1β and IL-10 (by approximately 50%) and PGE2 (by approximately 30%) after 40 h. Gas chromatography/ mass spectrometry identified terpinen-4-ol (42%), α-terpineol (3%) and 1,8-cineole (2%, respectively, of tea tree oil) as the water soluble components of tea tree oil. When these components were examined individually, only terpinen-4-ol suppressed the production after 40 h of TNFα, IL-1β, IL-8, IL-10 and PGE2 by LPS-activated monocytes. Conclusion: The water-soluble components of tea tree oil can suppress pro-inflammatory mediator production by activated human monocytes.
- 1 November 2000
- Published by Springer Nature in Inflammation Research
- Vol. 49 (11) , 619-626
Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes
Objective and Design: To evaluate potential anti-inflammatory properties of tea tree oil, the essential oil steam distilled from the Australian native plant, Melaleuca alternifolia.¶Material and Methods: The ability of tea tree oil to reduce the production in vitro of tumour necrosis factor-α (TNFα), interleukin (IL)-1β, IL-8, IL-10 and prostaglandin E2 (PGE2) by lipopolysaccharide (LPS)-activated human peripheral blood monocytes was examined.¶Results: Tea tree oil emulsified by sonication in a glass tube into culture medium containing 10% fetal calf serum (FCS) was toxic for monocytes at a concentration of 0.016% v/v. However, the water soluble components of tea tree oil at concentrations equivalent to 0.125% significantly suppressed LPS-induced production of TNFα, IL-1β and IL-10 (by approximately 50%) and PGE2 (by approximately 30%) after 40 h. Gas chromatography/ mass spectrometry identified terpinen-4-ol (42%), α-terpineol (3%) and 1,8-cineole (2%, respectively, of tea tree oil) as the water soluble components of tea tree oil. When these components were examined individually, only terpinen-4-ol suppressed the production after 40 h of TNFα, IL-1β, IL-8, IL-10 and PGE2 by LPS-activated monocytes. Conclusion: The water-soluble components of tea tree oil can suppress pro-inflammatory mediator production by activated human monocytes.